Clinical Trials Directory

Trials / Completed

CompletedNCT00486551

Anger Control Training for Youth With Tourette Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
11 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This is a clinical study of a cognitive-behavioral therapy known as anger control training in adolescents with Tourette Syndrome and explosive, disruptive behavior. ACT is compared to treatment as usual (TAU) in a randomized clinical trial.

Detailed description

This is a randomized controlled study of a cognitive-behavioral, anger control training (ACT) in adolescents with Tourette Syndrome (TS) complicated by disruptive behavior. Disruptive behaviors in TS may take numerous forms including noncompliance, anger outbursts, and physical aggression. Anger outbursts in TS have been described as rage attacks or rage storms due to their high intensity and unpredictability in response to minimal provocation. Whether these behaviors are part of TS, related to comorbid conditions, or due to the burden of chronic illness is not clear. Nevertheless, these disruptive behaviors can result in significant functional impairment and often require clinical attention. The purpose of the ACT intervention is to improve the explosive and noncompliant behavior in adolescents with TS by enhancing affect regulation and social problem-solving skills. The treatment is based on anger control training which has been empirically supported for reducing aggressive behaviors and improving social functioning in aggressive youths. The primary outcome measures include the parent-rated Oppositional Defiant Scale and the Clinicians Global Improvement Score assessed by a clinician blind to treatment assignment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAnger control training

Timeline

Start date
2001-08-01
Completion
2006-01-01
First posted
2007-06-14
Last updated
2022-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00486551. Inclusion in this directory is not an endorsement.